Pace Gary W's Form 4 filing
Cardiff Oncology, Inc. (CRDF) · filed Dec 12, 2024
- Accession no.
- 0000950170-24-135767
- Filed
- Dec 12, 2024
- Trade date
- Dec 11, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $940.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pace Gary WCIK 0001184778 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | Common Stock | PPurchaseAcquired | +350,115 | $2.60 | +$910,299 | 1,047,876 | Direct | |
| Dec 11, 2024 | Common Stock | PPurchaseAcquired | +11,500 | $2.60 | +$29,900 | 1,059,376 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.